Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02162732
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:00.259572+00:00
Published At
2024-04-05T00:00:00+00:00
Record Updated At
2025-11-03
Results Posted At
2024-04-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Neuroblastoma", "Medulloblastoma", "Glioma", "Ependymoma", "Choroid Plexus Neoplasms", "Craniopharyngioma", "Dysembryoplastic Neuroepithelial Tumor", "Meningioma", "Primitive Neuroectodermal Tumors (PNETs)", "Germ Cell Tumors", "Rhabdomyosarcoma", "Non-rhabdomyosarcoma", "Ewings Sarcoma", "Osteosarcoma", "Wilms Tumor", "Renal Cell Carcinoma", "Malignant Rhabdoid Tumor", "Clear Cell Sarcoma", "Liver Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-03"
protocolSection.identificationModule.nctId
"NCT02162732"
protocolSection.identificationModule.officialTitle
"Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-04-05"

Study condition terms

  • Neuroblastoma (protocolSection.conditionsModule.conditions)
  • Medulloblastoma (protocolSection.conditionsModule.conditions)
  • Glioma (protocolSection.conditionsModule.conditions)
  • Ependymoma (protocolSection.conditionsModule.conditions)
  • Choroid Plexus Neoplasms (protocolSection.conditionsModule.conditions)
  • Craniopharyngioma (protocolSection.conditionsModule.conditions)
  • Dysembryoplastic Neuroepithelial Tumor (protocolSection.conditionsModule.conditions)
  • Meningioma (protocolSection.conditionsModule.conditions)
  • Primitive Neuroectodermal Tumors (PNETs) (protocolSection.conditionsModule.conditions)
  • Germ Cell Tumors (protocolSection.conditionsModule.conditions)
  • Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Non-rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Ewings Sarcoma (protocolSection.conditionsModule.conditions)
  • Osteosarcoma (protocolSection.conditionsModule.conditions)
  • Wilms Tumor (protocolSection.conditionsModule.conditions)
  • Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Malignant Rhabdoid Tumor (protocolSection.conditionsModule.conditions)
  • Clear Cell Sarcoma (protocolSection.conditionsModule.conditions)
  • Liver Tumors (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.